Robert Reiter, MD

Dr. Reiter is the Bing Professor of Urologic Oncology and Chief, Division of Urologic Oncology at UCLA. He is Principal Investigator on UCLA's Prostate Cancer SPORE. His research is focused on anatomical and molecular imaging of prostate cancer, as well as elucidation of the molecular mechanisms of prostate cancer progression.

Financial relationships

Attribution:
Self

Type of financial relationship:
Consultant or Advisor (Oncology)

Ineligible company:
Pfizer

Date added:

Date updated:
11/28/2022
Attribution:
Self

Type of financial relationship:
Consultant or Advisor (Oncology)

Ineligible company:
Lantheus

Date added:

Date updated:
11/28/2022
Attribution:
Self

Type of financial relationship:
Consultant or Advisor (Oncology)

Ineligible company:
Point biopharma

Date added:

Date updated:
11/28/2022
Attribution:
Self

Type of financial relationship:
Meeting Participant or Lecturer (Oncology)

Ineligible company:
Bayer

Date added:

Date updated:
11/28/2022
Attribution:
Self

Type of financial relationship:
Meeting Participant or Lecturer (Specialty Not Specified)

Ineligible company:
Genomic Health

Date added:

Date updated:
11/28/2022
Attribution:
Self

Type of financial relationship:
Consultant or Advisor (Specialty Not Specified)

Ineligible company:
Janssen

Date added:

Date updated:
11/28/2022
Attribution:
Self

Type of financial relationship:
Investment Interest (Specialty Not Specified)

Ineligible company:
ImaginAb Corporation

Date added:

Date updated:
11/28/2022

Return to Transmisión Web: Avances globales en cáncer de próstata: el rol de las pruebas genéticas y los inhibidores de PARP (2022) - Español